Researchers say woman treated for neuroblastoma as a child is longest known survivor after having CAR T-cell therapy

A groundbreaking study in Nature Medicine reveals that GD2 CAR-T cell therapy can lead to long-term remission in children with neuroblastoma, with one...

Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now discovered that CAR...

CARsgen Therapeutics Holdings Limited, a company focused on innovative CAR T─cell therapies for the treatment of hematologic malignancies and solid...

A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman School of Medicine at...

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system caused by the immune system. B cells, which are a type of...

A new study has found that a common type of cancer treatment, called immune checkpoint inhibitors (ICIs), may not be very effective for patients who...

Imugene's trial programs could result in the first 'off the shelf' Car-T therapy that uses healthy donors' cells. ...

An experimental therapy AHA-1031 significantly reduced the size of treatment-resistant lung cancer tumors in animal models by stimulating an immune...

Mitochondrial damage is common in metabolic diseases like Diabetes, affecting insulin production and function in patients. Diabetics’...